TY - JOUR
T1 - Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans
AU - Powell, A M
AU - Albert, S
AU - Oyama, N
AU - Sakuma-Oyama, Y
AU - Bhogal, B
AU - Black, M M
PY - 2004/5
Y1 - 2004/5
N2 - We report a patient with chronic lymphocytic leukaemia who developed paraneoplastic pemphigus (PNP) soon after the initiation of fludarabine therapy. He presented with severe oral and cutaneous erosions. Initially, he had high titres of circulating autoantibodies as detected by indirect immunofluorescence (IF) on multiple epithelial substrates (normal human skin, monkey oesophagus, and rat bladder) and by desmoglein I and 3 enzyme-linked immunosorbent assays (ELISAs). His oral erosions have subsequently progressed into unusual hyperplastic papillomatous lesions affecting the inner aspect of lips and buccal mucosae, histologically consistent with pemphigus vegetans. Desmoglein 1 antibodies and IF on rat bladder substrate have become negative after 18 months of therapy. Several agents had been initiated to bring the disease under control originally, but a partial remission was achieved and maintained with mycophenolate mofetil and low-dose prednisolone.
AB - We report a patient with chronic lymphocytic leukaemia who developed paraneoplastic pemphigus (PNP) soon after the initiation of fludarabine therapy. He presented with severe oral and cutaneous erosions. Initially, he had high titres of circulating autoantibodies as detected by indirect immunofluorescence (IF) on multiple epithelial substrates (normal human skin, monkey oesophagus, and rat bladder) and by desmoglein I and 3 enzyme-linked immunosorbent assays (ELISAs). His oral erosions have subsequently progressed into unusual hyperplastic papillomatous lesions affecting the inner aspect of lips and buccal mucosae, histologically consistent with pemphigus vegetans. Desmoglein 1 antibodies and IF on rat bladder substrate have become negative after 18 months of therapy. Several agents had been initiated to bring the disease under control originally, but a partial remission was achieved and maintained with mycophenolate mofetil and low-dose prednisolone.
UR - http://www.scopus.com/inward/record.url?scp=2442610919&partnerID=8YFLogxK
U2 - 10.1111/j.1468-3083.2004.00917.x
DO - 10.1111/j.1468-3083.2004.00917.x
M3 - Article
VL - 18
SP - 360
EP - 364
JO - Journal of The European Academy of Dermatology and Venereology
JF - Journal of The European Academy of Dermatology and Venereology
IS - 3
ER -